Inventor
RAVETCH JEFFREY V
US32 patents
⚠️ This page may combine multiple inventors who share the name “RAVETCH JEFFREY V”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
UNIV ROCKEFELLER
19 patentsUS7416726B2Aug 26, 2008
Enhancement of antibody-mediated immune responses
UNIV ROCKEFELLER120 citations98
US6676927B1Jan 13, 2004
Animal model and methods for its use in the selection of cytotoxic antibodies
UNIV ROCKEFELLER91 citations98
US10479838B2Nov 19, 2019
Antibodies to CD40 with enhanced agonist activity
UNIV ROCKEFELLER7 citations82
US10894835B2Jan 19, 2021
Antibodies to CD40 with enhanced agonist activity
UNIV ROCKEFELLER5 citations81
US10882917B2Jan 5, 2021
Anti-tumor agents and methods of use
UNIV ROCKEFELLER2 citations72
US12384848B2Aug 12, 2025
Anti-inflammatory polypeptides
UNIV ROCKEFELLER0 citations62
US11613579B2Mar 28, 2023
Anti-inflammatory polypeptides
UNIV ROCKEFELLER0 citations62
US11608379B2Mar 21, 2023
Anti-inflammatory polypeptides
UNIV ROCKEFELLER0 citations62
US10894832B2Jan 19, 2021
Anti-inflammatory polypeptides
UNIV ROCKEFELLER0 citations62
US10844125B2Nov 24, 2020
Anti-inflammatory polypeptides
UNIV ROCKEFELLER1 citations62
US12577315B2Mar 17, 2026
Antibodies to CD40 with enhanced agonist activity
UNIV ROCKEFELLER0 citations60
US11760805B2Sep 19, 2023
Antibodies to CD40 with enhanced agonist activity
UNIV ROCKEFELLER0 citations60
US12186385B2Jan 7, 2025
Immune complex
UNIV ROCKEFELLER0 citations57
US11690905B2Jul 4, 2023
Immune complex
UNIV ROCKEFELLER0 citations57
US10973904B2Apr 13, 2021
Immune complex
UNIV ROCKEFELLER0 citations57
US9657101B2May 23, 2017
FC mutants
UNIV ROCKEFELLER1 citations57
US9587025B2Mar 7, 2017
Non-sialylated anti-inflammatory polypeptides
UNIV ROCKEFELLER0 citations51
US10300127B2May 28, 2019
Immune complex
UNIV ROCKEFELLER0 citations47
US9340607B2May 17, 2016
Anitbodies specific for the protofibril form of beta-amyloid protein
UNIV ROCKEFELLER0 citations47
RAVETCH JEFFREY V
7 patentsUS8470318B2Jun 25, 2013
Polypeptides with enhanced anti-inflammatory and decreased cytotoxic properties and relating methods
RAVETCH JEFFREY V28 citations87
US7846744B2Dec 7, 2010
Methods of identifying anti-inflammatory compounds
RAVETCH JEFFREY V8 citations79
US8470321B2Jun 25, 2013
Antibodies specific for the protofibril form of beta-amyloid protein
RAVETCH JEFFREY V8 citations78
US10167332B2Jan 1, 2019
Polypeptides with enhanced anti-inflammatory and decreased cytotoxic properties and relating methods
RAVETCH JEFFREY V5 citations64
US8618251B1Dec 31, 2013
Fc mutants
RAVETCH JEFFREY V4 citations57
US9845358B2Dec 19, 2017
Anti-inflammatory polypeptides
RAVETCH JEFFREY V0 citations51
US9134310B2Sep 15, 2015
Methods of identifying anti-inflammatory compounds
RAVETCH JEFFREY V0 citations47
SLOAN KETTERING INST CANCER
4 patentsUS5877396AMar 2, 1999
Mice mutant for functional Fc receptors and method of treating autoimmune diseases
SLOAN KETTERING INST CANCER145 citations96
US7038031B1May 2, 2006
DNA encoding FcγR receptor protein on NK cells
SLOAN KETTERING INST CANCER9 citations73
US5824487AOct 20, 1998
Method for screening for targets for anti-inflammatory or anti-allergic agents
SLOAN KETTERING INST CANCER13 citations66
US5116965AMay 26, 1992
Methods of obtaining histidine-rich protein genes of Plasmodia, and DNA obtained therefrom
SLOAN KETTERING INST CANCER4 citations54